应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02697 真健康医疗-B
未开盘 07-31 16:08:40
550.500
+13.000
+2.42%
最高
572.500
最低
538.000
成交量
2.04万
今开
555.000
昨收
537.500
日振幅
6.42%
总市值
196.24亿
流通市值
196.24亿
总股本
3,565万
成交额
1,147万
换手率
0.06%
流通股本
3,565万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
【IPO前哨】溶瘤病毒先驱亦诺微赴港:核心团队“顶配”,三年亏超15亿
港股解码 · 07-20
【IPO前哨】溶瘤病毒先驱亦诺微赴港:核心团队“顶配”,三年亏超15亿
一周港股牛熊榜 | 真健康医疗-B受手术机器人题材催化爆升74%,卓越睿新牵手阿里云涨逾40%;德适-B高估值回调近37%,钧达股份预亏拖累跌逾34%
老虎资讯综合 · 07-17
一周港股牛熊榜 | 真健康医疗-B受手术机器人题材催化爆升74%,卓越睿新牵手阿里云涨逾40%;德适-B高估值回调近37%,钧达股份预亏拖累跌逾34%
真健康医疗(02697)盘中涨13.90% 机构指其为首家覆盖“穿刺+消融+器官保存”的高端医疗设备公司
金吾财讯 · 07-16
真健康医疗(02697)盘中涨13.90% 机构指其为首家覆盖“穿刺+消融+器官保存”的高端医疗设备公司
港股直击 | 真健康医疗-B再创新高升超10%,上市半个月累计飙升近320%
老虎资讯综合 · 07-14
港股直击 | 真健康医疗-B再创新高升超10%,上市半个月累计飙升近320%
八年跑出三个“加速度”?拆解真健康医疗(02697)的产品、市场与资本的“快”密码
智通财经 · 07-13
八年跑出三个“加速度”?拆解真健康医疗(02697)的产品、市场与资本的“快”密码
真健康医疗-B早盘涨超23% 公司为经皮穿刺手术机器人龙头
新浪港股 · 07-13
真健康医疗-B早盘涨超23% 公司为经皮穿刺手术机器人龙头
港股异动 | 真健康医疗-B(02697.HK)早盘涨超9% 公司为经皮穿刺手术机器人龙头 今年放量值得期待
智通财经 · 07-13
港股异动 | 真健康医疗-B(02697.HK)早盘涨超9% 公司为经皮穿刺手术机器人龙头 今年放量值得期待
真健康医疗-B 6月股份维持稳定
公告速递 · 07-07
真健康医疗-B 6月股份维持稳定
异动解读|真健康医疗-B盘中下跌5.99%,上市一周短期涨幅过大引发持续回调
行情直击 · 07-06
异动解读|真健康医疗-B盘中下跌5.99%,上市一周短期涨幅过大引发持续回调
真健康医疗-B最终发售价定为每股126.2港元
投资观察 · 07-03
真健康医疗-B最终发售价定为每股126.2港元
港股午评|恒生指数早盘涨1.57% 铜业股涨幅居前
智通财经 · 07-03
港股午评|恒生指数早盘涨1.57% 铜业股涨幅居前
异动解读|真健康医疗-B盘中下跌7.89%,报414.8港元
行情直击 · 07-03
异动解读|真健康医疗-B盘中下跌7.89%,报414.8港元
港股异动 | 真健康医疗-B(02697)涨超9% 公司聚焦经皮穿刺手术机器人 机构料其有望9月入通
智通财经 · 07-03
港股异动 | 真健康医疗-B(02697)涨超9% 公司聚焦经皮穿刺手术机器人 机构料其有望9月入通
港股异动 | 真健康医疗-B(02697.HK)涨超9% 公司聚焦经皮穿刺手术机器人 机构料其有望9月入通
智通财经 · 07-03
港股异动 | 真健康医疗-B(02697.HK)涨超9% 公司聚焦经皮穿刺手术机器人 机构料其有望9月入通
【特约大V】邓声兴:美第三季度开局不利,恒指或随外围走低
金吾财讯 · 07-02
【特约大V】邓声兴:美第三季度开局不利,恒指或随外围走低
港股异动 | 真健康医疗-B(02697.HK)盘中涨超21% 公司经皮手术机器人市占第一
智通财经 · 07-02
港股异动 | 真健康医疗-B(02697.HK)盘中涨超21% 公司经皮手术机器人市占第一
穿刺+消融全栈闭环:拆解真健康(02697)医疗的产品矩阵与长期成长壁垒
智通财经 · 06-30
穿刺+消融全栈闭环:拆解真健康(02697)医疗的产品矩阵与长期成长壁垒
港股速报 | 恒科早盘小幅高开 四只新股上市三涨一破发 MLCC龙头今起招股
每日经济新闻 · 06-30
港股速报 | 恒科早盘小幅高开 四只新股上市三涨一破发 MLCC龙头今起招股
异动解读 | 新股上市获近1800倍超额认购,真健康医疗-B盘中大涨169.26%
异动解读 · 06-30
异动解读 | 新股上市获近1800倍超额认购,真健康医疗-B盘中大涨169.26%
真健康医疗-B香港首秀飙涨,股价冲上350港元,远超发行价126.20港元
美股速递 · 06-30
真健康医疗-B香港首秀飙涨,股价冲上350港元,远超发行价126.20港元
加载更多
公司概况
公司名称:
真健康医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
于中国从事经皮穿刺手术及消融手术机器人研发及商业化。
发行价格:
--
{"stockData":{"symbol":"02697","market":"HK","secType":"STK","nameCN":"真健康医疗-B","latestPrice":550.5,"timestamp":1785485320098,"preClose":537.5,"halted":0,"volume":20420,"delay":0,"changeRate":0.024186046511627906,"floatShares":35647000,"shares":35647003,"eps":-3.4289157861220914,"marketStatus":"未开盘","change":13,"latestTime":"07-31 16:08:40","open":555,"high":572.5,"low":538,"amount":11465766,"amplitude":0.064186,"askPrice":550.5,"askSize":60,"bidPrice":547,"bidSize":20,"shortable":0,"etf":0,"ttmEps":-3.2526806888763415,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785720600000},"marketStatusCode":0,"adr":0,"listingDate":1782748800000,"exchange":"SEHK","adjPreClose":537.5,"openAndCloseTimeList":[[1785461400000,1785470400000],[1785474000000,1785484800000]],"volumeRatio":0.6899907420204975,"lotSize":20,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02697","defaultTab":"news","newsList":[{"id":"2653781363","title":"【IPO前哨】溶瘤病毒先驱亦诺微赴港:核心团队“顶配”,三年亏超15亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2653781363","media":"港股解码","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653781363?lang=zh_cn&edition=full","pubTime":"2026-07-20 15:56","pubTimestamp":1784534160,"startTime":"0","endTime":"0","summary":"截至2026年7月7日,公司研发管线拥有两款针对实体瘤的溶瘤免疫疗法产品。招股书披露,亦诺微医药至今没有任何产品销售收入,全部收入来自对外授权和合作安排。本次IPO不仅是公司拓宽融资渠道、支撑全球临床开发的融资窗口,更是市场对“溶瘤病毒+外泌体双商业模式”价值的一次集中定价考验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI2MDAzMTQ4OA==&mid=2650513680&idx=2&sn=58ffec752dc2276dd3ddb53f575c7989&chksm=f260d47fc5175d696c888ae87f2d3f1146b6fb45b54c0e147a564e3b884e9ff4523f0b6608f2#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK1191","BK1574","09637","02697","BK1515","BK1161","09939","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168059671","title":"一周港股牛熊榜 | 真健康医疗-B受手术机器人题材催化爆升74%,卓越睿新牵手阿里云涨逾40%;德适-B高估值回调近37%,钧达股份预亏拖累跌逾34%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168059671","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168059671?lang=zh_cn&edition=full","pubTime":"2026-07-17 17:24","pubTimestamp":1784280294,"startTime":"0","endTime":"0","summary":"总结全周(7月13日-7月17日),恒生指数涨387.12点或1.6%,恒生科技指数跌98.49点或2.09%。本周涨幅居前个股中,真健康医疗-B受手术机器人稀缺性及高端医疗器械政策催化,累计上涨74%;卓越睿新与阿里云合作推进AI教学及科研场景落地,本周上涨40.03%;维立志博-B因六项研究入选ESMO、核心管线进入优先审评,累计上涨29.21%。跌幅方面,德适-B在高估值及持续亏损压力下累计下跌36.94%;钧达股份预告上半年最高亏损2.7亿元,累计下跌34.83%;建滔积层板在PCB涨价线高位回落下累计下跌33.15%。","market":"hk","thumbnail":"https://static.tigerbbs.com/cb1639b5fc4982ccb82111d6af456d9b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/cb1639b5fc4982ccb82111d6af456d9b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03277","02526","01888","02889","02865","09887","06127","00148","02697","02687","BK4588"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2651490715","title":"真健康医疗(02697)盘中涨13.90% 机构指其为首家覆盖“穿刺+消融+器官保存”的高端医疗设备公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2651490715","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651490715?lang=zh_cn&edition=full","pubTime":"2026-07-16 11:13","pubTimestamp":1784171623,"startTime":"0","endTime":"0","summary":"消息面上,西牛证券新近研究指,真健康医疗是中国首家同时覆盖“穿刺+消融+器官保存”三条机器人技术路线的高端医疗设备公司,目前拥有四款核心经皮穿刺手术机器人,均已在肺及腹部穿刺手术取得第三类注册证,定位于不同级别医院,形成完整产品梯队。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986035","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159891","02697","159873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179804647","title":"港股直击 | 真健康医疗-B再创新高升超10%,上市半个月累计飙升近320%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179804647","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179804647?lang=zh_cn&edition=full","pubTime":"2026-07-14 10:59","pubTimestamp":1783997966,"startTime":"0","endTime":"0","summary":"继昨日突破500港元后, $真健康医疗-B(02697)$ 今日再度冲高破顶。7月14日盘中股价一度触及533.5港元,再创上市以来新高;截至发稿,股价报530港元,涨幅10.69%,总市值接近190亿港元。以126.2港元的发售价计算,上市半个月累计涨幅接近320%。消息面上,国务院日前印发《国民健康“十五五”规划》,明确提出全链条支持创新药和医疗器械发展应用,优化创新药和临床急需药品审评审批;加大对高端医疗器械关键核心技术、元器件和整机研发的支持力度;推动人工智能赋能医药全产业链升级;健全医保支持创新药和医疗器械高质量发展机制。","market":"hk","thumbnail":"https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRcocpXuOAnDfqWojIP7jsGZ2vv5ONPTC_NywVMEV9ujQ&s","type":0,"news_type":0,"thumbnails":["https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRcocpXuOAnDfqWojIP7jsGZ2vv5ONPTC_NywVMEV9ujQ&s"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02697"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651719198","title":"八年跑出三个“加速度”?拆解真健康医疗(02697)的产品、市场与资本的“快”密码","url":"https://stock-news.laohu8.com/highlight/detail?id=2651719198","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651719198?lang=zh_cn&edition=full","pubTime":"2026-07-13 15:48","pubTimestamp":1783928935,"startTime":"0","endTime":"0","summary":"2022年5月,TH-S1取得国内经皮穿刺手术机器人领域首张三类医疗器械注册证;2023年6月,TH-S获批并被国家药监局认定为“国内首创”;2024年9月,TH-X MW获批用于肝肿瘤治疗,并被认定为“国际首创”;2026年4月,TH-X MW适应症进一步扩展至肺肿瘤治疗。截至目前,不包括耗材,真健康医疗已取得8项国家药监局三类医疗器械注册证及2项二类医疗器械注册证,共10款产品取得上市许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1466523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02697","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651885160","title":"真健康医疗-B早盘涨超23% 公司为经皮穿刺手术机器人龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2651885160","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651885160?lang=zh_cn&edition=full","pubTime":"2026-07-13 11:15","pubTimestamp":1783912500,"startTime":"0","endTime":"0","summary":" 真健康医疗-B盘中涨超23%,截至发稿,股价上涨22.38%,现报445.20港元,成交额1882.04万港元。 公开资料显示,真健康医疗核心产品为经皮穿刺手术机器人,共四个型号,均已获得国家药监局三类注册证,获批应用于肺部及腹部穿刺。根据灼识咨询的资料,按2025年经皮穿刺手术机器人的收入计量,公司在中国位居首位,市场份额为28.0%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-13/doc-inihrnpk9112832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MDEV","HTEC","02697","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651627481","title":"港股异动 | 真健康医疗-B(02697.HK)早盘涨超9% 公司为经皮穿刺手术机器人龙头 今年放量值得期待","url":"https://stock-news.laohu8.com/highlight/detail?id=2651627481","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651627481?lang=zh_cn&edition=full","pubTime":"2026-07-13 09:57","pubTimestamp":1783907856,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02697"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161440206","title":"真健康医疗-B 6月股份维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1161440206","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161440206?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:13","pubTimestamp":1783412022,"startTime":"0","endTime":"0","summary":"广东真健康医疗科技开发股份有限公司于2026年7月7日发布截至2026年6月30日的股份变动月报表。公司确认自上市日起即符合香港联合交易所有限公司主板上市规则所要求的最低公众持股量。股本结构整体保持稳定。公司表示将继续严格遵守香港联合交易所《上市规则》及相关法律法规。截至6月底,公司总股本保持不变,发行在外股数为35,647,003股。本次公告由执行董事陈妙娉于2026年7月7日签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02697"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148930374","title":"异动解读|真健康医疗-B盘中下跌5.99%,上市一周短期涨幅过大引发持续回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1148930374","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148930374?lang=zh_cn&edition=full","pubTime":"2026-07-06 09:41","pubTimestamp":1783302079,"startTime":"0","endTime":"0","summary":"7月6日,真健康医疗-B盘中下跌5.99%,报397.8港元/股,成交额225.49万港元。该股于6月30日以126.2港元发售价登陆港交所,上市首日收报400港元,短期累计涨幅超过200%。此前7月3日已出现明显回调,盘中跌幅一度超过7%。公司目前仍处于商业化初期,2025年主营收入仅约1218万元人民币,年度净亏损约9013万元,累计亏损达15.37亿元,高估值下短期获利盘抛压持续释放。公司主要于中国从事经皮穿刺手术及消融手术机器人研发及商业化。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02697"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129031465","title":"真健康医疗-B最终发售价定为每股126.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129031465","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129031465?lang=zh_cn&edition=full","pubTime":"2026-07-03 19:14","pubTimestamp":1783077289,"startTime":"0","endTime":"0","summary":"真健康医疗科技发展有限公司(股票代码:2697.HK)宣布,其最终发售价已确定为每股126.2港元。这一价格的确立,标志着公司上市进程中的关键一步已顺利完成。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02697"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648965893","title":"港股午评|恒生指数早盘涨1.57% 铜业股涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2648965893","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648965893?lang=zh_cn&edition=full","pubTime":"2026-07-03 12:00","pubTimestamp":1783051235,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,港股恒生指数涨1.57%,涨361点,报23416点;恒生科技指数涨2.02%。港股早盘成交1661亿港元。铜业股涨幅居前。市场加息预期明显降温,机构指铜股错杀修复窗口期将至。埃斯顿涨21%,拟收购具身智能机器人企业埃斯顿酷卓;来福谐波涨超16%。卧安机器人涨超11%,根据激励计划进一步购买H股,获董事会主席作出自愿延长禁售承诺。黄金股全线上涨。保利置业集团盈警后跌4.9%,上半年预亏7亿至8亿元,同比由盈转亏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462767.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01258","LU0211977185.USD","LU0149721374.USD","LU0173614495.USD","LU0572944931.SGD","LU0979878070.USD","LU0181495838.USD","09088","BK1206","LU0228659784.USD","LU0886674414.USD","07552","07500","09115","BK1555","02715","BK1166","LU1224709979.USD","BK1535","LU1831875114.USD","SG9999002463.SGD","07226","03032","LU0329678170.USD","LU0540923850.HKD","LU0266512127.USD","LU1988902786.USD","HK0000306685.HKD","SG9999014674.SGD","LU1064131342.USD","LU1303224171.USD","HK0000320264.USD","BK1544","03088","09067","LU0328353924.USD","LU2399975544.HKD","LU0417516902.SGD","LU0821914370.USD","IE0032431581.USD","BK1505","LU0327786744.USD","BK1613","03330","513600","LU0828237940.HKD","LU0106959298.USD","LU0348825331.USD","LU0828237510.HKD","02837","BK1214","03419","HK0000306701.USD","03033","03115","BK1190","LU0307460666.USD","SG9999004220.SGD","LU0043850808.USD","BK1183","LU0797268264.HKD","LU1794554557.SGD","LU0918141705.HKD","LU0918141887.USD","LU1048596156.SGD","LU0871576103.HKD","LU1188198961.HKD","LU1719994722.HKD","LU2097828714.EUR","82800","03952","HK0000320223.HKD","LU0266512473.USD","LU2097828805.USD","BK1198","LU1770034418.SGD","03067","BK1617","LU0164880469.USD","LU1769817096.USD","07200","LU0096374516.USD","LU1242518857.USD","02899","LU0061477393.USD","LU2097828474.EUR","LU2097828631.EUR","LU0140636845.USD","LU2097828557.USD","LU0463099449.HKD","LU0082770016.USD","LU0868486357.SGD","LU1481107354.HKD","LU0345780281.USD","09880","BK1191","LU0431992006.USD","LU0287142896.SGD","LU2039709279.SGD","02697","LU0531971595.HKD","02800","BK1240","LU0620787316.HKD","LU0106252389.USD","LU3063872942.SGD","LU0326950275.SGD","LU0348735423.USD","LU0348827113.USD","LU1251922891.USD","01138","02252","LU0737861699.HKD","LU0164865239.USD","03423","LU0370786039.SGD","LU1720050803.USD","LU2177674079.SGD","03417","LU0737861772.HKD","LU0469268626.HKD","LU2008162690.USD","LU0329678337.USD","LU0244354667.USD","HHImain","LU0345780521.USD","LU0588546209.SGD","BK1592","LU1242518931.SGD","LU0164939612.USD","01818","LU1769817179.HKD","BK1594","HSTECH","LU0348816934.USD","LU0456854461.SGD","LU0082770016.SGD","LU0561508036.HKD","LU1961090484.USD","LU0348814723.USD","00119","600026","LU2264538146.SGD","LU1504937902.USD","601899","LU0048580855.USD","002747","LU2226246903.HKD","BK1100","01208","MCHmain","LU1105468828.SGD","03037","ZIJMY","LU0417516738.SGD","02833","06600","LU1808992512.USD","LU0634319403.HKD","LU0165289439.USD","LU0049853897.USD","83115","LU1282648689.USD","07300","HSI","LU0039217434.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119490483","title":"异动解读|真健康医疗-B盘中下跌7.89%,报414.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119490483","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119490483?lang=zh_cn&edition=full","pubTime":"2026-07-03 09:56","pubTimestamp":1783043780,"startTime":"0","endTime":"0","summary":"7月3日,真健康医疗-B盘中下跌7.89%,报414.8港元/股,成交额879.25万港元。该股于6月30日以126.2港元发售价登陆港交所,上市首日收报400港元,此后连续走高,短期累计涨幅显著,今日出现回调。公司主要于中国从事经皮穿刺手术及消融手术机器人研发及商业化。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02697"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648563706","title":"港股异动 | 真健康医疗-B(02697)涨超9% 公司聚焦经皮穿刺手术机器人 机构料其有望9月入通","url":"https://stock-news.laohu8.com/highlight/detail?id=2648563706","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648563706?lang=zh_cn&edition=full","pubTime":"2026-07-03 09:54","pubTimestamp":1783043644,"startTime":"0","endTime":"0","summary":"据悉,真健康医疗是一家专注于经皮穿刺手术及消融手术机器人18A企业。根据灼识咨询的资料,按2025年经皮穿刺手术机器人的收入计量,公司在中国位居首位,市场份额为28.0%。值得一提的是,恒生指数公司或于8月25日公布半年度指数调整结果,所有变动将于9月7日起生效,届时沪深交易所会相应调整港股通可投资标的范围。华泰证券预测真健康医疗有望纳入港股通。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","VXUS","02697","ROBO","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648057637","title":"港股异动 | 真健康医疗-B(02697.HK)涨超9% 公司聚焦经皮穿刺手术机器人 机构料其有望9月入通","url":"https://stock-news.laohu8.com/highlight/detail?id=2648057637","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648057637?lang=zh_cn&edition=full","pubTime":"2026-07-03 09:54","pubTimestamp":1783043644,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02697"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578018","title":"【特约大V】邓声兴:美第三季度开局不利,恒指或随外围走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578018","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648578018?lang=zh_cn&edition=full","pubTime":"2026-07-02 09:45","pubTimestamp":1782956725,"startTime":"0","endTime":"0","summary":"国指跌47点或0.62%,报7558点。科指升79点或1.8%,报4472点。美第三季度开局不利,恒指或随外围走低。小分子D&M业务收入69.3亿元,按年激增80.1%,创单季历史新高;TIDES业务收入23.8亿元,客户数与服务分子数分别按年提升28%及59%,公司预计全年TIDES收入增长约40%。截至3月底,持续经营业务在手订单达597.7亿元,按年增长23.6%,为未来增长奠定坚实基础。考虑到公司CRDMO龙头地位、小分子D&M强劲增长及TIDES业务爆发潜力,估值仍具向上修复空间。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/NmQyMzI4NWZmMGRlNDRmMTg4YmIyOTUwMDI3OTAzODMzODA5NjYxNDI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NmQyMzI4NWZmMGRlNDRmMTg4YmIyOTUwMDI3OTAzODMzODA5NjYxNDI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984931","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["513600","02697","02833","603259","LU2242644610.SGD","83115","02800","02359","LU1046422090.SGD","LU0348766576.USD","03419","06915","HSI","BK1576","BK1583","LU0348767384.USD","03037","MCHmain","82800","09115","03115","HHImain","HSTECH","LU2045819591.USD","07200","03952","LU0052750758.USD","LU0320764599.SGD","06715","07500","LU0708995583.HKD","LU2125910500.SGD","BK1141","07300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648573078","title":"港股异动 | 真健康医疗-B(02697.HK)盘中涨超21% 公司经皮手术机器人市占第一","url":"https://stock-news.laohu8.com/highlight/detail?id=2648573078","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648573078?lang=zh_cn&edition=full","pubTime":"2026-07-02 09:37","pubTimestamp":1782956225,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02697"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647584180","title":"穿刺+消融全栈闭环:拆解真健康(02697)医疗的产品矩阵与长期成长壁垒","url":"https://stock-news.laohu8.com/highlight/detail?id=2647584180","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647584180?lang=zh_cn&edition=full","pubTime":"2026-06-30 12:42","pubTimestamp":1782794561,"startTime":"0","endTime":"0","summary":"截至上午收市,报375.2港元,涨幅为197.3%。真健康的产品矩阵,相比同业到底强在哪?经皮穿刺与消融赛道,至今有两大行业级难题没有被传统方案彻底解决。其中最具标志性的是2022年5月获批的TH-S1,它是国内首款集齐智能影像重建、红外双目导航、六自由度机械臂、实时呼吸追踪四大系统的经皮穿刺机器人。全行业 21 款获批穿刺机器人,真健康独占 5 款,是第二名的 2.5 倍。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02697","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647358601","title":"港股速报 | 恒科早盘小幅高开 四只新股上市三涨一破发 MLCC龙头今起招股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647358601","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647358601?lang=zh_cn&edition=full","pubTime":"2026-06-30 10:17","pubTimestamp":1782785850,"startTime":"0","endTime":"0","summary":"今日(6月30日),港股市场迎来2026年上半年最后一个交易日,早间市场表现平稳,恒科小幅高开。早间开盘,恒生指数报23007.87点,低开18.81点,跌幅0.08%;恒生科技指数开盘报4416.68点,上涨23.67点,涨幅0.54%。今日市场焦点,同程旅行(HK00780)拟全面要约收购嘀嗒出行(HK02559)。今日早间,嘀嗒出行涨超80%,同程旅行跌超4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606303787890297.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606303787890297.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["300408","07226","06715","02837","03088","03032","LU0278937759.USD","SGXZ90724238.SGD","00780","LU1115378108.SGD","02697","07552","LU0315179316.USD","BK1604","09088","BK1615","03067","03417","02559","BK1516","SG9999001051.SGD","BK1255","06951","BK1164","03033","HSTECH","LU0640798160.USD","03952","03423","09067","LU2460026573.USD","SG9999001093.SGD","HSI","SG9999001226.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166259942","title":"异动解读 | 新股上市获近1800倍超额认购,真健康医疗-B盘中大涨169.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166259942","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166259942?lang=zh_cn&edition=full","pubTime":"2026-06-30 09:38","pubTimestamp":1782783488,"startTime":"0","endTime":"0","summary":"真健康医疗-B今日盘中股价大幅飙升,涨幅高达169.26%,引起市场高度关注。消息面上,此次股价异动主要源于该股今日在港交所主板首次挂牌上市。公司本次发行价为每股126.20港元,香港公开发售部分获得了市场狂热追捧,整体认购倍数高达1790.4倍,一手中签率仅为2.00%,显示出极高的打新热度。综合来看,作为新股上市,极高的市场认购热情和积极的暗盘表现是推动真健康医疗-B股价在交易时段内大幅走高的核心因素。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02697"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103175368","title":"真健康医疗-B香港首秀飙涨,股价冲上350港元,远超发行价126.20港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103175368","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103175368?lang=zh_cn&edition=full","pubTime":"2026-06-30 09:33","pubTimestamp":1782783194,"startTime":"0","endTime":"0","summary":"真健康医疗-B在香港交易所闪亮登场,其股价在上市首日便展现出惊人的爆发力,一举冲至每股350港元的高位。这一表现与每股126.20港元的发行价形成了鲜明对比,涨幅令人瞩目,为近期港股市场增添了一抹亮色。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02697"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.truehealth.cn","stockEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.3762},{"period":"3month","weight":3.3621},{"period":"ytd","weight":3.3621}],"compareEarnings":[{"period":"1week","weight":0.0369},{"period":"1month","weight":0.1313},{"period":"3month","weight":0.0042},{"period":"6month","weight":-0.0549},{"period":"1year","weight":0.0449},{"period":"ytd","weight":0.0099}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"于中国从事经皮穿刺手术及消融手术机器人研发及商业化。","exchange":"SEHK","name":"真健康医疗-B","nameEN":"TH MEDICAL-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"真健康医疗-B(02697)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供真健康医疗-B(02697)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"真健康医疗-B,02697,真健康医疗-B股票,真健康医疗-B股票老虎,真健康医疗-B股票老虎国际,真健康医疗-B行情,真健康医疗-B股票行情,真健康医疗-B股价,真健康医疗-B股市,真健康医疗-B股票价格,真健康医疗-B股票交易,真健康医疗-B股票购买,真健康医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"真健康医疗-B(02697)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供真健康医疗-B(02697)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}